Endovascular Repair of Thoracic Aortoenteric Fistulas

Abstract

Aortoesophageal fistula is a rare manifestation of thoracic aortic surgery or esophageal disease. We describe a patient who underwent emergent endovascular repair of an aortoesophageal fistula due to a ruptured penetrating ulcer of the descending thoracic aorta and review the literature on this subject.

Aortoesophageal Fistula Occurring during Lung Cancer Treatment: A Case Treated by Thoracic Endovascular Aortic Repair

“…Aortoesophageal fistula still has a high mortality rate, for which preoperative hemodynamics and mediastinitis are significant prognostic factors (4). Patients treated soon after the onset of aortoesophageal fistula with prosthetic reconstruction of the aorta and esophagectomy with curative intent are more likely to survive than those with delayed treatment.…”

Combined Thoracic Endovascular Aortic Repair and Neurosurgical Intervention for Injury Due to Posterior Spine Surgery

“…Endovascular stenting to repair iliac vessel injuries complicating spinal surgery has been previously well described . Thoracic endovascular aortic repair (TEVAR), first described by Dake in 1994, currently represents a first option strategy for many patients with a thoracic aortic pathology . The use of TEVAR in aortic trauma has contributed to a reduction of both mortality and morbidity mainly due to the incidence of postoperative respiratory failure and paraplegia seen after open aortic surgery …”

“…[17][18][19][20] Thoracic endovascular aortic repair (TEVAR), first described by Dake in 1994, currently represents a first option strategy for many patients with a thoracic aortic pathology. [21][22][23][24][25][26] The use of TEVAR in aortic trauma has contributed to a reduction of both mortality and morbidity mainly due to the incidence of postoperative respiratory failure and paraplegia seen after open aortic surgery. [27][28][29][30][31][32][33][34][35] Thoracic endografting allows the repair of focal aortic perforations with a low incidence of endoleak or graft migration that would need a secondary intervention.…”